Clinical Trial Update: PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration [NA]

View source ↗

Summary

A completed clinical trial comparing PEEK versus a silicon interspinous spacer to reduce supradjacent segment degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adjacent Segment Degeneration

Drugs mentioned

• PEEK interspinous spacer
• Silicon interspinous spacer

Snippet

Sponsor: University Hospital of Patras | Conditions: Adjacent Segment Degeneration | NA | Status: COMPLETED